M’s Science Corporation

In many ways, Mebiopharm's investment experience is illustrative of the challenges facing the bioventure sector as a whole in Japan, or indeed anywhere else. The need to secure sufficient funding and

The November 2011 collaboration between Otsuka Pharmaceutical Co. Ltd. and Lundbeck Inc. involving central nervous system candidates from both companies was and remains an outlier when reviewi

Attention deficit hyperactivity disorder (ADHD) Alzheimer's disease Anxiety Depression Epilepsy Huntington's disease Insomnia Pain Schizophrenia Other Source: Scrip analysis